Article
siRNA screen identifies QPCT as a druggable target for Huntington's disease.
Nature chemical biology - 1 May 2015
Jimenez-Sanchez Maria, Lam Wun, Hannus Michael, Sönnichsen Birte, Imarisio Sara, Fleming Angeleen, Tarditi Alessia, Menzies Fiona, Dami Teresa Ed, Xu Catherine, Gonzalez-Couto Eduardo, Lazzeroni Giulia, Heitz Freddy, Diamanti Daniela, Massai Luisa, Satagopam Venkata P, Marconi Guido, Caramelli Chiara, Nencini Arianna, Andreini Matteo, Sardone Gian Luca, Caradonna Nicola P, Porcari Valentina, Scali Carla, Schneider Reinhard, Pollio Giuseppe, O'Kane Cahir J, Caricasole Andrea, Rubinsztein David C
Abstract excerpt
Huntington's disease (HD) is a currently incurable neurodegenerative condition caused by an abnormally expanded polyglutamine tract in huntingtin (HTT). We identified new modifiers of mutant HTT toxicity by performing a large-scale 'druggable genome' siRNA screen in human cultured cells, followed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
